Frost & Sullivan releases the 'Tumor Innovation Drug Market Industry Research Report'

The incidence and mortality rates of tumors continue to increase, becoming a major threat to human health. In recent years, with the continuous development of targeted and immunotherapy treatments, significant breakthroughs have been made in tumor treatment. However, there are still unmet clinical needs in areas such as breast cancer and gastric cancer. For this reason, based on research into this market, Frost & Sullivan (Frost & Sullivan) has released a relevant industry report.